Are Wall Street 'target prices' truly reliable?

Understanding how target prices are formed and how valuations are derived can make you a better investor. The key is not to treat extreme target prices as the intrinsic value of a stock, nor to place excessive faith in a single number. When investors consider buying a stock, the ultimate question always boils down to: What is it worth? This is the very question every Wall Street analyst seeks to answer when preparing a research report on a company. Analysts often respond by assigning a target price—typically representing where they expect the stock to trade over the next 12 months. These target prices frequently appear in TV reports, Barron’s articles, and elsewhere. Sometimes, the target itself becomes news—for instance, in 1998, Henry Blodget predicted that e-commerce upstart Amazon (AMZN) would reach $400 per share. At the time, Amazon was trading around $240—but just three weeks later, its share price hit Blodget’s $400 target. More recently, J.P. Morgan (JPM) analyst Stephen Tusa set a $10 target price for General Electric (GE), which proved prescient (Editor’s note: GE has fallen 20.2% over the past year and closed at $10.07 on July 18). Yet for stock price forecasting, target prices aren’t always useful. Many professional fund managers express skepticism, viewing them largely as marketing tools employed by brokerage firms to generate investor interest in particular stocks. In fact, Barron’s found that among S&P 500 constituents, 28 stocks rated ‘Buy’ (or equivalent) carried target prices *below* their current market prices—including Deere (DE), Walmart (WMT), Costco (COST), and Abbott Laboratories (ABT). For investors, the assumptions underpinning analysts’ price targets are not always transparent. Take Cisco Systems (CSCO), a Wall Street favorite. We interviewed two analysts covering the company. Both issued ‘Buy’ recommendations and assigned similar target prices—but offered markedly different rationales for those valuations. (Barron’s agreed not to disclose the analysts’ identities.) The first analyst applied a 17x P/E ratio to forecast earnings per share for Cisco’s fiscal year ending July 2020—a multiple 30% above the company’s historical average. He argued that Cisco’s business model justified the elevated P/E, but offered no further explanation.

‘Middle Eastern tycoons’ increase positions! Foreign investors voice optimism! These stocks are seen as having substantial upside potential!

UBS Securities China equity strategy analyst Lei Meng also expressed bullish sentiment toward the A-share market, arguing that it now holds greater strategic importance for China’s economic development. Robust financing support from the stock market is indispensable for advancing new-quality productive forces and achieving comprehensive self-reliance and controllability. Fueled by net global capital inflows, China’s equity market has rebounded—and A-shares are expected to narrow their valuation discount relative to other emerging markets. While foreign institutions voice optimism, they’re also voting with real money. According to Wind data, northbound funds have injected RMB 92.723 billion into A-shares this year—far exceeding the full-year 2023 net inflow. This year, the A-share market touched bottom twice; since February 6, it has mounted a robust rebound. During this rally, 65 A-share companies saw their share prices double, 519 rose more than 50%, and 1,599 gained over 30%. Many foreign investors have reaped substantial paper gains. For example, Baolidi—a photolithography resin stock—has surged over 200% since the rally began. Notably, QFII investors Barclays Bank PLC and Goldman Sachs both newly entered its top-10 circulating shareholders list as of end-Q1 (see Figure 1). Since then, the stock has doubled again in Q2—making this timely positioning highly profitable. Similarly, Shen Nan Circuit, newly and heavily accumulated by Kuwait Investment Authority—the so-called ‘Middle Eastern tycoon’—has risen over 80% since the February 6 rebound (see Figure 2). Although QFII holdings for Q2 won’t be fully disclosed until mid-year reports are released, northbound fund flows already reveal foreign investors’ latest preferences. Based on the most recent holdings data, northbound funds increased positions in nearly 1,500 companies compared to end-Q1—with 149 seeing their stake in circulating A-shares rise by more than one percentage point. Huaming Equipment experienced the most dramatic增持: As of May 23, northbound funds held 136 million shares—up 43.5 million shares from end-Q1—lifting their stake in circulating shares by 5.73 percentage points. Its share price has climbed steadily, hitting an all-time high intraday on May 13 (see Figure 3). Beyond northbound funds, multiple companies have drawn strong consensus buy ratings from securities firms since May, accompanied by target prices implying significant upside. Among firms where northbound funds raised stakes by over one percentage point versus end-Q1, 22 brokerages have set target prices offering at least 30% upside from current levels. For instance, BorgWarner: Northbound funds now hold 48.645 million shares—increasing their stake in circulating shares by 1.15 percentage points since end-Q1. On May 2, Huatai Securities analyst Tingting Song noted in her report that the company posted steady growth in Q1 revenue and net profit attributable to shareholders; achieved key breakthroughs in joint-venture and overseas OEM business; and remains well-positioned to sustain outstanding order acquisition capability—driving revenue growth as existing orders are fulfilled.

Ashland Inc. Stock 12-Month Price Target Raised to $82.9, Implies 8% Upside

16 hours ago

Analysts raised Ashland Inc.'s average 12-month price target to $82.9, implying an 8% potential upside. The consensus rating remains Buy among 12 analysts covering the specialty chemicals firm.

TradingView

2026-04-01

Ashland Inc Stock: Specialty Chemicals Leader Faces Evolving Industrial Demands in 2026

2026-04-04

Allspring Global Investments Reduces Stake in Ashland Inc. to $25.69 Million

2026-04-06

Ashland Raises Prices Across Product Lines Amid Cost Pressures

2026-04-11

Ashland Inc. (NYSE:ASH) Given Consensus Rating of "Hold" by Analysts

2026-04-13

Massachusetts Financial Services Co. Lowers Stock Position in Ashland Inc.